Table 4.
Overview of prognostic, diagnostic and clinicopathological significance of circRNAs in pancreatic cancer tissues
No | Circ | Expression | Cut-off | Detect | Variables | AUC | Survival | Prognostic biomarker | Reference | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Size | Differentiation | T | Lymphatic (N) | Distance (M) | TNM | Vessel invasion | Other | |||||||||
1 | 0001946/0005397 | Up | qRT-PCR | 27,997,903 | ||||||||||||
2 | 0006913/0000257/0005785/0041150/0008719 | Down | qRT-PCR | 27,997,903 | ||||||||||||
3 | 100433/101717/102049/102051/102619/103076/103390/104084/104270 | Up | qRT-PCR | 29,620,241 | ||||||||||||
4 | 000167 | Down | qRT-PCR | 29,620,241 | ||||||||||||
5 | 0001946 | Up | qRT-PCR | 33,593,338 | ||||||||||||
6 | 0006215 | Up | qRT-PCR | 29,930,719 | ||||||||||||
7 | 0066147 | Up | qRT-PCR | 32,855,541 | ||||||||||||
8 | 0007334 | Up | qRT-PCR | 31,428,151 | ||||||||||||
9 | 0000816 | Up | qRT-PCR | 32,217,695 | ||||||||||||
10 | chr12:74,678,804–74,700,449 | Up | qRT-PCR and FISH | + | + | 32,879,441 | ||||||||||
11 | ciRS-7 | Up | qRT-PCR | + | + | 30,898,507 | ||||||||||
12 | 0013912 | Up | qRT-PCR | + | + | 32,884,344 | ||||||||||
13 | 0006988 | Up | qRT-PCR | + | + | + | + | 29,307,994 | ||||||||
14 | 0050102 | Up | qRT-PCR | + | 33,289,016 | |||||||||||
15 | 0000662 | Down | qRT-PCR | + | 33,425,718 | |||||||||||
16 | 0099999 | qRT-PCR | + | 30,537,731 | ||||||||||||
17 | 0075829 | Up | qRT-PCR | + | + | 33,184,989 | ||||||||||
18 | 0007334 | Up | qRT-PCR | + | 33,832,516 | |||||||||||
19 | 0000977 | Up in high-HIF1A PC tissues | qRT-PCR | 31,402,756 | ||||||||||||
20 | 0071036 | Up | MEL | qRT-PCR | + | PET-CT SUVmax value | 0.65 | OS | + | 33,507,122 | ||||||
21 | 0000677 | Up | MEL | qRT-PCR | + | + | + | OS | + | 33,413,045 | ||||||
22 | 0000069 | Up | qRT-PCR | + | + | 0.8944 | 33,324,055 | |||||||||
23 | 0,060,055 | Up | qRT-PCR | + | 0.9093 | 33,469,368 | ||||||||||
24 | 0036627 | Up | MEL | qRT-PCR | + | + | + | OS | + | 29,709,702 | ||||||
25 | 0001460 | Up | MEL | qRT-PCR | + | OS | + | 33,750,389 | ||||||||
26 | 0007534 | Up | MEL | qRT-PCR | + | + | OS | + | 30,382,592 | |||||||
27 | IARS | Up | MEL | qRT-PCR | + | + | + | OS | + | 30,064,461 | ||||||
28 | 0030235 | Up | qRT-PCR | + | + | OS | + | 30,591,218 | ||||||||
29 | ASH2L | Up | qRT-PCR | + | + | OS | + | 31,718,694 | ||||||||
30 | 0001013 | Up | MEL | qRT-PCR | + | + | + | + | OS | 33,563,550 | ||||||
31 | ADAM9 | Up | qRT-PCR | + | + | OS | 31,810,373 | |||||||||
32 | 0000284 | Up | qRT-PCR | GEM resistance | OS | 32,104,074 | ||||||||||
33 | LDLRAD3 | Up | qRT-PCR | OS | 31,521,692 | |||||||||||
34 | 0001568 | Up | qRT-PCR and FISH | OS | 32,193,152 | |||||||||||
35 | 03955 | Up | qRT-PCR | OS | 33,864,618 | |||||||||||
36 | 0009065 | Up | qRT-PCR | + | OS/DFS | + | 32,375,768 | |||||||||
37 | 0092314 | Up | MEL | qRT-PCR | + | + | + | OS/DFS | 33,842,379 | |||||||
38 | 0005273 | Up | qRT-PCR | + | + | OS/PFS | 33,275,224 | |||||||||
39 | 0001649 | Down | MV | qRT-PCR | + | + | OS | + | 29,969,694 | |||||||
40 | 0000979 | Down | MEL | qRT-PCR | + | + | OS | 32,878,470 | ||||||||
41 | 0086375 | Down | qRT-PCR | + | + | OS/DFS | + | 32,366,257 |
MEL: Median Expression Level; MV: Mean Value; GEM: Gemcitabine; AUC: Area Under the Curve; OS: Overall Survival; DFS: Disease-free Survival; PFS: Progression-free survival